Russell Investments Group Ltd. increased its holdings in Artivion, Inc. (NYSE:AORT – Free Report) by 17.5% in the 1st quarter, according to its most recent filing with the SEC. The institutional investor owned 169,594 shares of the company’s stock after buying an additional 25,234 shares during the quarter. Russell Investments Group Ltd. owned about 0.40% of Artivion worth $4,169,000 at the end of the most recent reporting period.
Several other large investors also recently bought and sold shares of the business. Peregrine Capital Management LLC purchased a new position in Artivion in the first quarter worth about $7,650,000. Point72 Asset Management L.P. purchased a new position in Artivion in the fourth quarter worth about $5,573,000. First Trust Advisors LP purchased a new position in Artivion in the fourth quarter worth about $4,771,000. Thornburg Investment Management Inc. purchased a new position in Artivion in the first quarter worth about $3,261,000. Finally, Universal Beteiligungs und Servicegesellschaft mbH purchased a new position in Artivion in the first quarter worth about $3,162,000. 86.37% of the stock is currently owned by institutional investors.
Insiders Place Their Bets
In related news, CEO James P. Mackin sold 12,500 shares of the company’s stock in a transaction on Friday, August 15th. The stock was sold at an average price of $42.32, for a total transaction of $529,000.00. Following the completion of the sale, the chief executive officer directly owned 852,783 shares in the company, valued at $36,089,776.56. This represents a 1.44% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this link. Also, insider John E. Davis sold 10,802 shares of the stock in a transaction dated Tuesday, August 12th. The shares were sold at an average price of $43.67, for a total value of $471,723.34. Following the completion of the sale, the insider owned 208,778 shares of the company’s stock, valued at approximately $9,117,335.26. This trade represents a 4.92% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders sold 96,538 shares of company stock worth $3,444,651. Insiders own 7.60% of the company’s stock.
Analysts Set New Price Targets
Read Our Latest Stock Analysis on AORT
Artivion Stock Up 3.9%
Shares of AORT opened at $44.8140 on Friday. The stock has a market capitalization of $2.11 billion, a price-to-earnings ratio of -106.70 and a beta of 1.64. Artivion, Inc. has a 1 year low of $21.97 and a 1 year high of $45.07. The business’s 50 day simple moving average is $33.65 and its 200-day simple moving average is $28.87. The company has a debt-to-equity ratio of 0.52, a current ratio of 4.78 and a quick ratio of 3.48.
Artivion (NYSE:AORT – Get Free Report) last released its earnings results on Thursday, August 7th. The company reported $0.24 earnings per share for the quarter, beating the consensus estimate of $0.11 by $0.13. The firm had revenue of $112.97 million for the quarter, compared to the consensus estimate of $107.96 million. Artivion had a positive return on equity of 5.70% and a negative net margin of 4.43%.The business’s quarterly revenue was up 15.3% on a year-over-year basis. Artivion has set its FY 2025 guidance at EPS. As a group, equities analysts expect that Artivion, Inc. will post 0.37 earnings per share for the current fiscal year.
About Artivion
Artivion, Inc manufactures, processes, and distributes medical devices and implantable human tissues worldwide. The company provides BioGlue, a polymer consisting of bovine blood protein and an agent for cross-linking proteins for cardiac, vascular, neurologic, and pulmonary procedures; cardiac preservation services; PhotoFix, a bovine pericardial patch; and aortic arch stent grafts including E-vita Open Plus and E-vita Open Neo.
Featured Stories
- Five stocks we like better than Artivion
- Pets Are Big Business: 4 Big-Ticket Pet Stocks to Add to Your Portfolio
- Royal Caribbean Earnings Beat Fuels Strong 2025 Outlook
- How to Calculate Stock Profit
- Alphabet’s Breakout Potential: From Laggard to AI Leader
- What is a Microcap Stock? Everything You Need to Know
- TJX Stock Price Hits Fresh High, Signals More Highs to Follow
Receive News & Ratings for Artivion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Artivion and related companies with MarketBeat.com's FREE daily email newsletter.